Analysis of the gyrA Gene of Clinical Yersinia ruckeri Isolates with Reduced Susceptibility to Quinolones

Applied and Environmental Microbiology

Volumn 70, Issue 1, 2004, Pages 599-602

  Gibello, Alicia ^a   Concepcion Porrero M ^a   Mar Blanco, M ^a   Vela, Ana I ^a   Liébana, Pilar ^a   Moreno, Miguel A ^a   Fernández Garayzábal, José F ^a   Domínguez, Lucas ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; DISEASES; ELECTROPHORESIS; ESCHERICHIA COLI; GENES;

ANTIMICROBIAL SUSCEPTIBILITY;

MICROBIOLOGY;

ARGININE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENE PRODUCT; NALIDIXIC ACID; OXOLINIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PISCICULTURE; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE; YERSINIA RUCKERI;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTI-INFECTIVE AGENTS; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; FISH DISEASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NALIDIXIC ACID; ONCORHYNCHUS MYKISS; OXOLINIC ACID; QUINOLONES; YERSINIA RUCKER;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; YERSINIA; YERSINIA RUCKERI;

EID: 0345830585     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.70.1.599-602.2004     Document Type: Article

References (28)

1. Akasaka, T., M. Tanaka, A. Yamaguchi, and K. Sato, 2001. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeriginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolonc resistance. Antimicrob. Agents Chemother. 45:2263-2268.
2. Baranwal, S., K. Dey, T. Ramamurthy, G. B. Nair, and M. Kundu. 2002. Role of active efflux in association with target gene mutations in fluoroquinolones resistance in clinical isolates of Vibrio cholerac. Antimicrob. Agents Chemother. 46:2676-2678.
3. Barnard, F. M., and A. Maxwell. 2001. Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser83 and Asp87. Antimicrob. Agents Chemother. 45:1994-2000.
4. Blanco, M., A. Gibello, A. I. Vela, M. A. Moreno, L. Dominguez, and J. F. Fernández-Garayzábal. 2002. PCR detection and PFGE macrorestriction analyses of clinical isolates of Pseudomonas anguilliseptica from winter discase outbreaks in sea bream Sparus auratus. Dis. Aquat. Org. 50:19-27.
5. Coquet, L., P. Cosette, L. Quillet, F. Petit, G. A. Junter, and T. Jouenne. 2002. Occurrence and phenotypic characterization of Yersinia ruckeri strains with biofilm-forming capacity in a rainbow trout farm. Appl. Environ. Microbiol. 68:470-475.
6. Furones, M. D., C. J. Rodgers, and C. B. Munn. 1993. Yersinia ruckeri, the causal agent of enteric redmouth disease (ERM) in fish. Annu. Rev. Fish Dis. 3:105-125.
7. Gibello, A., M. M. Blanco, M. A. Moreno, M. T. Cutuli, A. Doménech, L. Domínguez, and J. F. Fernández-Garayzá bal. 1999. Development of a PCR assay for detection of Yersinia ruckeri in tissues of inoculated and naturally infected trout. Appl. Environ. Microbiol. 65:346-350.
8. Gofil-Urriza, M., C. Arpin, M. Capdepuy, V. Dubois, P. Caumette, and C. Quentin. 2002. Type 11 topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance. Antimicrob. Agents Chemother. 46:350-359.
9. Grave, K., A. Markestad, and M. Bangen. 1996. Comparison in prescribing patterns of antibacterial drugs in salmonid farming in Norway during the periods 1980-1988 and 1989-1994. J. Vet. Pharmacol. Ther. 19:184-191.
10. Hooper, D. C. 2001. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin. Infect. Dis. 32:9-15.
11. Kim, J. H., E. H. Cho, K. S. Kim, H. P. Kim, and Y. M. Kim. 1998. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates. Antimicrob. Agents Chemother. 42:190-193.
12. Lawson, P. A., S. E. Gharbia, H. N. Shah, and D. R. Clark. 1989. Recognition of Fusobacterium nucleatum subgroups Fn-1, Fn-2 and Fn-3 ribosomal RNA gene restriction patterns. FEMS Microbiol. Lett. 65:41-46.
13. Ledo, A., C. P. Dopazo, J. L. Romalde, A. E. Toranzo, and J. L. Barja. 1987. Effectiveness of different chemotherapeutic agents for controlling bacterial fish diseases. Bull. Eur. Assoc. Fish Pathol. 7:20-22.
14. Lipsitch, M., and R. Levin. 1997. The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41:363-373.
15. National Committee for Clinical Laboratory Standards. 1989. Methods for antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Oppegaard, H., and H. Sφrum. 1994. gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida. Antimicrob. Agents Chemother. 38:2460-2464.
17. Oraic, D., S. Zrncic, B. Sostaric, D. Bazulic, and Z. Lipej. 2002. Occurrence of enteric redmouth disease in rainbow trout (Oncorhynchus mykiss) on farms in Croatia. Acta Vet. Hung. 50:283-291.
18. Rodgers, C. J. 2001. Resistance of Yersinia ruckeri to antimicrobial agents in vitro. Aquaculture 196:325-345.
19. Rodgers, C. J., and B. Austin. 1983. Oxolinic acid for control of enteric redmouth disease in rainbow trout. Vet. Rec. 112:83.
20. Romalde, J. L., J. L. Barja, B. Magariños, and A. E. Toranzo. 1994. Starvation-survival processes of the bacterial fish pathogen Yersinia ruckeri. Syst. Appl. Microbiol. 17:161-168.
21. Schmidt, A. S., M. S. Bruun, I. Dalsgaard, K. Pedersen, and J. L. Larsen. 2000. Occurrence of antimicrobial resistance in fish-pathogenic and environmental bacteria associated with four Danish rainbow trout farms. Appl. Environ. Microbiol. 66:4908-4915.
22. Tavio, M., J. Vile, J. Ruiz, A. M. Martín-Sánchez, and M. T. Jiménez de Anta. 2000. Decreased permeability and enhanced protondependent active efflux in the development of resistance to quinolones in Morganella morganii strains. Int. J. Antimicrob. Agents 14:157-160.
23. Vela, A. I., J. F. Fernández-Garayzábal, M. V. Latre, A. A. Rodríguez, L. Domínguez, and M. A. Moreno. 2001. Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep. Int. J. Antimicrob. Agents 17:215-220.
24. Vila, J., L. Olmos, J. Ballesteros, J. A. Vázquez, M. J. Giménez, F. Marco, and L. Aguilar. 1997. Development of in-vivo resistance after quinolone treatment of gonococcal urethritis. J. Antimicrob. Chemother. 39:841.
25. Webber, M., and L. J. V. Piddock. 2001. Quinolone resistance in Escherichia coli. Vet. Res. 32:275-284.
26. Weigel, L. M., C. D. Steward, and F. C. Tenover. 1998. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42:2661-2667.
27. Willmott, C. J. R., and A. Maxwell. 1993. A single point mutation in the DNA gyrase A protein greatly reduces the binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob. Agents Chemother. 37:126-127.
28. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.